Xilio Therapeutics, Inc.
Pharmaceutical company · Waltham, Massachusetts, United States · Nasdaq: XLO
Xilio Therapeutics, Inc. is a pharmaceutical company headquartered in Waltham, Massachusetts, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker XLO. It has reported private securities offerings to the US SEC, most recently $95 million sold in a notice filed in 2021.
Xilio Therapeutics at a glance
What does Xilio Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $95 million sold (2021).
Frequently asked questions about Xilio Therapeutics
Where is Xilio Therapeutics headquartered?
Xilio Therapeutics, Inc. is headquartered in Waltham, Massachusetts, United States.
What does Xilio Therapeutics do?
Xilio Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Xilio Therapeutics a public company?
Yes. Xilio Therapeutics, Inc. trades on Nasdaq under the ticker XLO.
When was Xilio Therapeutics founded?
The earliest incorporation on record for Xilio Therapeutics, Inc. is in 2020, according to public company registers.
Similar companies
- Mustang Bio, Inc.Waltham, Massachusetts, United States
- Alkermes IncWaltham, Massachusetts, United States
- Spyre Therapeutics, Inc.Waltham, Massachusetts, United States
- Cogent Biosciences, Inc.Waltham, Massachusetts, United States
- Viridian Therapeutics, Inc.\DEWaltham, Massachusetts, United States
- Dyne Therapeutics, Inc.Waltham, Massachusetts, United States
- Korsana Biosciences, Inc.Waltham, Massachusetts, United States
- Jade Biosciences, Inc.Waltham, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences